Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infection in systemic lupus erythematosus

M Petri1

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Rheumatic Diseases Clinics of North America
|June 2, 1998
PubMed
Summary

Systemic lupus erythematosus (SLE) patient survival has improved due to better treatments and antibiotics. However, increased immunosuppressive drug use presents challenges in identifying and treating infections in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collapse of Nuclear Collectivity along the N=Z Line.

Physical review letters·2026
Same author

Author Correction: An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

Electromagnetic properties of nuclei from first principles: a case for synergies between experiment and theory.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2024
Same author

Study of the N=32 and N=34 Shell Gap for Ti and V by the First High-Precision Multireflection Time-of-Flight Mass Measurements at BigRIPS-SLOWRI.

Physical review letters·2023
Same author

The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort.

Seminars in arthritis and rheumatism·2020

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Nephrology

Background:

  • Systemic lupus erythematosus (SLE) patient survival has significantly improved since the 1950s.
  • Advances in supportive care for renal failure and the availability of antibiotics have contributed to this improved survival.
  • The widespread use of immunosuppressive agents, particularly alkylating drugs, is a cornerstone of SLE management.

Purpose of the Study:

  • To highlight the evolving challenges in managing infections in SLE patients.
  • To underscore the impact of increased immunosuppression and prolonged survival on infection identification and treatment.

Main Methods:

  • This abstract is a review of the challenges in SLE patient care.
  • It synthesizes information on treatment advancements and their consequences.
  • Focuses on the interplay between immunosuppression and infection risk.

Main Results:

  • Improved survival rates in SLE patients are documented.
  • Increased use of immunosuppressives, including alkylating drugs, is noted.
  • The identification and treatment of infections in SLE patients remain a significant clinical challenge.

Conclusions:

  • While SLE patient survival has improved, the use of immunosuppressive therapies introduces complexities in managing infections.
  • Ongoing vigilance and appropriate treatment strategies are crucial for addressing infection risks in long-term SLE survivors.
  • The balance between immunosuppression for SLE and infection prevention requires careful clinical consideration.

Related Experiment Videos